Guararapes Confeccoes SA
BOVESPA:GUAR3
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.67
11.76
|
| Price Target |
|
We'll email you a reminder when the closing price reaches BRL.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Wall Street
Price Targets
GUAR3 Price Targets Summary
Guararapes Confeccoes SA
According to Wall Street analysts, the average 1-year price target for
GUAR3
is 14.15 BRL
with a low forecast of 13.13 BRL and a high forecast of 15.75 BRL.
Price Targets
Operating Income
Forecast
Operating Income Estimate
Guararapes Confeccoes SA
For the last 13 years the
compound annual growth rate for
Guararapes Confeccoes SA's operating income is
4%.
The projected
CAGR
for the next 4 years is
15%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is GUAR3's stock price target?
Price Target
14.15
BRL
According to Wall Street analysts, the average 1-year price target for
GUAR3
is 14.15 BRL
with a low forecast of 13.13 BRL and a high forecast of 15.75 BRL.
What is Guararapes Confeccoes SA's Revenue forecast?
Projected CAGR
9%
For the last 13 years the
compound annual growth rate for
Guararapes Confeccoes SA's revenue is
9%.
The projected
CAGR
for the next 4 years is
9%.
What is Guararapes Confeccoes SA's Operating Income forecast?
Projected CAGR
15%
For the last 13 years the
compound annual growth rate for
Guararapes Confeccoes SA's operating income is
4%.
The projected
CAGR
for the next 4 years is
15%.
What is Guararapes Confeccoes SA's Net Income forecast?
Projected CAGR
46%
For the last 13 years the
compound annual growth rate for
Guararapes Confeccoes SA's net income is
-3%.
The projected
CAGR
for the next 3 years is
46%.